查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
感染疾病诊断市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1416293

感染疾病诊断市场报告：2030 年趋势、预测与竞争分析

Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

感染疾病诊断的趋势和预测

到 2030 年，全球感染疾病诊断市场预计将达到 499 亿美元，2024 年至 2030 年复合年增长率为 5.1%。该市场的主要驱动因素是感染疾病病率的增加以及对疾病早期检测的认识不断提高。全球感染疾病诊断市场的未来前景广阔，免疫诊断、NGS、INAAT 和 PCR 市场充满机会。

感染疾病诊断市场洞察

Lucintel 预计，由于这些产品的重复使用，在整个预测期内，试剂、套件和消耗品将继续成为最大的细分市场。

由于在 COVID-19感染疾病和 POC传染病检查等测试中越来越多地使用免疫测量，免疫诊断将继续成为该市场的最大细分市场。

由于感染率高、医疗基础设施完善以及该地区医疗支出不断增加，北美在整个预测期内仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球感染疾病诊断市场预计将达到 499 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球感染疾病诊断市场预计将以5.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动因素是感染疾病的日益普及和人们对疾病早期检测的认识不断提高。

Q4.市场的主要细分市场是：

A4.感染疾病诊断市场前景广阔，免疫诊断、NGS、INAAT 和 PCR 市场充满机会。

Q5.市场的主要企业是：

A5. 主要感染疾病诊断公司如下。

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于试剂、套件和消耗品的重复使用，在整个预测期内，这些产品将继续成为最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于该地区的高感染率、完善的医疗基础设施以及不断上升的医疗成本，北美在整个预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球感染疾病诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球感染疾病诊断市场趋势（2018-2023）与预测（2024-2030）
  • 全球感染疾病诊断市场（按产品）
    • 试剂、套件及耗材
    • 装置
    • 软体和服务
  • 按测试类型分類的全球感染疾病诊断市场
    • 实验室
    • POC
  • 按技术分類的全球感染疾病诊断市场
    • 免疫诊断
    • NGS
    • INAAT
    • PCR
  • 按最终用途分類的全球感染疾病诊断市场
    • 医院
    • 实验室

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球感染疾病诊断市场
  • 北美感染疾病诊断市场
  • 欧洲感染疾病诊断市场
  • 亚太感染疾病诊断市场
  • 其他地区感染疾病诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球感染疾病诊断市场成长机会（按产品）
    • 按测试类型分類的全球感染疾病诊断市场成长机会
    • 全球感染疾病诊断市场的技术成长机会
    • 按最终用途分類的全球感染疾病诊断市场的成长机会
    • 全球感染疾病诊断市场按地区成长机会
  • 全球感染疾病诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球感染疾病诊断市场的能力
    • 全球感染疾病诊断市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson
简介目录

Infectious Disease Diagnostics Trends and Forecast

The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

A more than 150-page report is developed to help in your business decisions.

Infectious Disease Diagnostics by Segment

The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.

Infectious Disease Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Lab
  • POC

Infectious Disease Diagnostics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Immunodiagnostics
  • NGS
  • INAAT
  • PCR

Infectious Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Labs

Infectious Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infectious Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Infectious Disease Diagnostics Market Insights

Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in COVID-19 testing, POC infectious disease testing, and others.

North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Features of the Global Infectious Disease Diagnostics Market

Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).

Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the infectious disease diagnostics market size?

Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.

Q2. What is the growth forecast for infectious disease diagnostics market?

Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

Q4. What are the major segments for infectious disease diagnostics market?

Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.

Q5. Who are the key infectious disease diagnostics market companies?

Answer: Some of the key infectious disease diagnostics companies are as follows:

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Q6. Which infectious disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the infectious disease diagnostics market by product (reagents, kits, and consumables, instruments, and software & services), test type (lab and POC), technology (immunodiagnostics, NGS, INAAT, and PCR), end use (hospitals and labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Infectious Disease Diagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Infectious Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Infectious Disease Diagnostics Market by Product
    • 3.3.1: Reagents, Kits, and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software & Services
  • 3.4: Global Infectious Disease Diagnostics Market by Test Type
    • 3.4.1: Lab
    • 3.4.2: POC
  • 3.5: Global Infectious Disease Diagnostics Market by Technology
    • 3.5.1: Immunodiagnostics
    • 3.5.2: NGS
    • 3.5.3: INAAT
    • 3.5.4: PCR
  • 3.6: Global Infectious Disease Diagnostics Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Labs

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Infectious Disease Diagnostics Market by Region
  • 4.2: North American Infectious Disease Diagnostics Market
    • 4.2.2: North American Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.3: European Infectious Disease Diagnostics Market
    • 4.3.1: European Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.3.2: European Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.4: APAC Infectious Disease Diagnostics Market
    • 4.4.1: APAC Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.4.2: APAC Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.5: ROW Infectious Disease Diagnostics Market
    • 4.5.1: ROW Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.5.2: ROW Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Product
    • 6.1.2: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Technology
    • 6.1.4: Growth Opportunities for the Global Infectious Disease Diagnostics Market by End Use
    • 6.1.5: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global Infectious Disease Diagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Infectious Disease Diagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infectious Disease Diagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Thermo Fisher Scientific
  • 7.3: F. Hoffmann-La Roche
  • 7.4: bioMerieux
  • 7.5: Siemens Healthineers
  • 7.6: Danaher Corporation
  • 7.7: Becton and Dickinson